Isaacs; John T.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Isaacs; John T..The latest application filed is for "albumin-proaerolysin prodrugs".
- Isaacs; John T. - Phoenix MD
- Isaacs; John T. - Pheonix MD
- Isaacs; John T. - Baltimore MD
| Patent | Date |
|---|---|
| Albumin-proaerolysin Prodrugs App 20210205408 - Isaacs; John T. ; et al. | 2021-07-08 |
| Albumin-proaerolysin prodrugs Grant 10,967,046 - Isaacs , et al. April 6, 2 | 2021-04-06 |
| Albumin-proaerolysin Prodrugs App 20200268836 - Isaacs; John T. ; et al. | 2020-08-27 |
| Albumin-proaerolysin prodrugs Grant 10,596,226 - Isaacs , et al. | 2020-03-24 |
| Synthetic Enhancement Of The T-cell Armamentarium As An Anti-cancer Therapy App 20180148480 - Isaacs; John T. ; et al. | 2018-05-31 |
| Albumin-proaerolysin Prodrugs App 20180008668 - Isaacs; John T. ; et al. | 2018-01-11 |
| Tumor activated prodrugs Grant 8,957,016 - Denmeade , et al. February 17, 2 | 2015-02-17 |
| Tumor activated prodrugs Grant 8,822,406 - Denmeade , et al. September 2, 2 | 2014-09-02 |
| Activation of peptide prodrugs by hK2 Grant 8,450,280 - Denmeade , et al. May 28, 2 | 2013-05-28 |
| Activation of Peptide Prodrugs by hK2 App 20120309692 - Denmeade; Samuel R. ; et al. | 2012-12-06 |
| Tumor Activated Prodrugs App 20120270767 - Denmeade; Samuel R. ; et al. | 2012-10-25 |
| Tumor Activated Prodrugs App 20120270768 - Denmeade; Samuel R. ; et al. | 2012-10-25 |
| Activation of Peptide Prodrugs by HK2 App 20110245147 - Denmeade; Samuel R. ; et al. | 2011-10-06 |
| Activation of peptide prodrugs by hK2 Grant 7,906,477 - Denmeade , et al. March 15, 2 | 2011-03-15 |
| Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer Grant 7,838,266 - Denmeade , et al. November 23, 2 | 2010-11-23 |
| Proaerolysin Containing Protease Activation Sequences And Methods Of Use For Treatment Of Prostate Cancer App 20100234300 - Denmeade; Samuel R. ; et al. | 2010-09-16 |
| Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer Grant 7,745,395 - Denmeade , et al. June 29, 2 | 2010-06-29 |
| Tumor Activated Prodrugs App 20100120697 - Denmeade; Samuel R. ; et al. | 2010-05-13 |
| Tumor activated prodrugs Grant 7,635,682 - Denmeade , et al. December 22, 2 | 2009-12-22 |
| Tissue specific prodrugs Grant 7,468,354 - Isaacs , et al. December 23, 2 | 2008-12-23 |
| Activation of peptide prodrugs by hK2 App 20080247950 - Denmeade; Samuel R. ; et al. | 2008-10-09 |
| Proaerolysin Containing Protease Activation Sequences And Methods Of Use For Treatment Of Prostate Cancer App 20080089869 - Denmeade; Samuel R. ; et al. | 2008-04-17 |
| Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer Grant 7,282,476 - Denmeade , et al. October 16, 2 | 2007-10-16 |
| Tumor activated prodrugs App 20070160536 - Denmeade; Samuel R. ; et al. | 2007-07-12 |
| Activation of peptide prodrugs by hk2 App 20060217317 - Denmeade; Samuel R. ; et al. | 2006-09-28 |
| Activation of peptide prodrugs by hK2 App 20060183689 - Denmeade; Samuel R. ; et al. | 2006-08-17 |
| Activation of peptide prodrugs by hK2 Grant 7,053,042 - Denmeade , et al. May 30, 2 | 2006-05-30 |
| Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 App 20050250102 - Dong, Jin-Tang ; et al. | 2005-11-10 |
| Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer App 20040235095 - Denmeade, Samuel R. ; et al. | 2004-11-25 |
| Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 Grant 6,756,201 - Dong , et al. June 29, 2 | 2004-06-29 |
| Tissue specific prodrugs App 20040029778 - Isaacs, John T. | 2004-02-12 |
| Tissue specific prodrug Grant 6,504,014 - Isaacs , et al. January 7, 2 | 2003-01-07 |
| Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 App 20020058257 - Dong, Jin-Tang ; et al. | 2002-05-16 |
| Tissue specific prodrug Grant 6,265,540 - Isaacs , et al. July 24, 2 | 2001-07-24 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 